212 related articles for article (PubMed ID: 36947452)
41. circ_PPAPDC1A promotes Osimertinib resistance by sponging the miR-30a-3p/ IGF1R pathway in non-small cell lung cancer (NSCLC).
Tang YF; Liu ZH; Zhang LY; Shi SH; Xu S; Ma JA; Hu CH; Zou FW
Mol Cancer; 2024 May; 23(1):91. PubMed ID: 38715012
[TBL] [Abstract][Full Text] [Related]
42. circ_0008797 attenuates non-small cell lung cancer proliferation, metastasis, and aerobic glycolysis by sponging miR-301a-3p/SOCS2.
Abuduwaili K; Zhu X; Shen Y; Lu S; Liu C
Environ Toxicol; 2022 Jul; 37(7):1697-1710. PubMed ID: 35305058
[TBL] [Abstract][Full Text] [Related]
43. Circular RNA hsa_circ_0004689 (circSWT1) promotes NSCLC progression via the miR-370-3p/SNAIL axis by inducing cell epithelial-mesenchymal transition (EMT).
Long X; Wang DG; Wu ZB; Liao ZM; Xu JJ
Cancer Med; 2023 Apr; 12(7):8289-8305. PubMed ID: 36530171
[TBL] [Abstract][Full Text] [Related]
44. Circular RNA hsa_circ_0008003 promotes the progression of non-small-cell lung cancer by sponging miR-548I and regulating KPNA4 expression.
Yang W; Yao Y; Yang S; Ke Y
Thorac Cancer; 2023 Feb; 14(6):544-554. PubMed ID: 36573325
[TBL] [Abstract][Full Text] [Related]
45. Hsa_circ_0016760 exacerbates the malignant development of non‑small cell lung cancer by sponging miR‑145‑5p/FGF5.
Zhu Z; Wu Q; Zhang M; Tong J; Zhong B; Yuan K
Oncol Rep; 2021 Feb; 45(2):501-512. PubMed ID: 33416186
[TBL] [Abstract][Full Text] [Related]
46. Circ_0006220 promotes non-small cell lung cancer progression via sponging miR-203-3p and regulating RGS17 expression.
Wang S; Zhang C; Chen R
Hum Exp Toxicol; 2022; 41():9603271211062854. PubMed ID: 35041543
[TBL] [Abstract][Full Text] [Related]
47. Circ_0020123 regulates autophagy, glycolysis, and malignancy by upregulating IRF4 through eliminating miR-193a-3p-mediated suppression of IRF4 in non-small cell lung cancer.
Yang XP; Zheng YZ; Tan J; Tian RJ; Shen P; Cai WJ; Liao HY
Neoplasma; 2022 Mar; 69(2):392-403. PubMed ID: 35225648
[TBL] [Abstract][Full Text] [Related]
48. Circ_0000463 contributes to the progression and glutamine metabolism of non-small-cell lung cancer by targeting miR-924/SLC1A5 signaling.
Liu Y; Wang S; Pan S; Yan Q; Li Y; Zhao Y
J Clin Lab Anal; 2022 Jan; 36(1):e24116. PubMed ID: 34811815
[TBL] [Abstract][Full Text] [Related]
49. Circ_0030998 Restrains Cisplatin Resistance Through Mediating miR-1323/PDCD4 Axis in Non-small Cell Lung Cancer.
Zhu C; Jiang X; Xiao H; Guan J
Biochem Genet; 2022 Dec; 60(6):2434-2454. PubMed ID: 35460386
[TBL] [Abstract][Full Text] [Related]
50. CircRNA hsa_circ_0070659 predicts poor prognosis and promotes non-small cell lung cancer (NSCLC) progression via microRNA-377 (miR-377) / Ras-Associated Binding Protein 3C (RAB3C) pathway.
Meng Q; Li Y; Sun Z; Yang X
Bioengineered; 2022 Jun; 13(6):14578-14594. PubMed ID: 36694911
[TBL] [Abstract][Full Text] [Related]
51. Circ_0016760 accelerates non-small-cell lung cancer progression through miR-646/AKT3 signaling in vivo and in vitro.
Chen S; Zhou L; Ran R; Huang J; Zheng Y; Xing M; Cai Y
Thorac Cancer; 2021 Dec; 12(23):3223-3235. PubMed ID: 34658165
[TBL] [Abstract][Full Text] [Related]
52. Hsa_circ_0043265 Suppresses Proliferation, Metastasis, EMT and Promotes Apoptosis in Non-Small Cell Lung Cancer Through miR-25-3p/FOXP2 Pathway.
Ren T; Liu C; Hou J; Shan F
Onco Targets Ther; 2020; 13():3867-3880. PubMed ID: 32440153
[TBL] [Abstract][Full Text] [Related]
53. Circular RNA-UBE2D2 accelerates the proliferation and metastasis of non-small cell lung cancer cells via modulating microRNA-376a-3p/Eukaryotic Translation Initiation Factor 4γ2 axis.
Tong J; Lu J; Mao X; Zhu Z; Wang Y; Lou M; Zhang K
Bioengineered; 2022 Mar; 13(3):5942-5953. PubMed ID: 35196197
[TBL] [Abstract][Full Text] [Related]
54. Hsa_circ_0097922 promotes tamoxifen resistance and cell malignant behaviour of breast cancer cells by regulating ACTN4 expression via miR-876-3p.
Liang X; Liu X; Song Z; Zhu J; Zhang J
Clin Exp Pharmacol Physiol; 2022 Dec; 49(12):1257-1269. PubMed ID: 35856314
[TBL] [Abstract][Full Text] [Related]
55. A Regulatory Axis of circ_0008193/miR-1180-3p/TRIM62 Suppresses Proliferation, Migration, Invasion, and Warburg Effect in Lung Adenocarcinoma Cells Under Hypoxia.
Chen M; Huang X; Li L; Huang M; Cai R; Liao X
Med Sci Monit; 2020 Aug; 26():e922900. PubMed ID: 32782238
[TBL] [Abstract][Full Text] [Related]
56. hsa_circ_0062389 promotes the progression of non-small cell lung cancer by sponging miR-103a-3p to mediate CCNE1 expression.
She Y; Han Y; Zhou G; Jia F; Yang T; Shen Z
Cancer Genet; 2020 Feb; 241():12-19. PubMed ID: 31962276
[TBL] [Abstract][Full Text] [Related]
57. Circ_0062558 promotes growth, migration, and glutamine metabolism in triple-negative breast cancer by targeting the miR-876-3p/SLC1A5 axis.
Yuan M; Zhang J; He Y; Yi G; Rong L; Zheng L; Zhan T; Zhou C
Arch Gynecol Obstet; 2022 Nov; 306(5):1643-1655. PubMed ID: 35284960
[TBL] [Abstract][Full Text] [Related]
58. Circ_0074027 contributes to the progression of non-small cell lung cancer via microRNA-362-3p/clathrin heavy chain axis.
Jiang Z; Yin J; Peng G; Long X
Anticancer Drugs; 2021 Jan; 32(1):1-10. PubMed ID: 32932275
[TBL] [Abstract][Full Text] [Related]
59. Oncogenic circ-SLC16A1 promotes progression of non-small cell lung cancer via regulation of the miR-1287-5p/profilin 2 axis.
Jin M; Yuan T; Tian K; Li J; Huang Q; Chi Y; Huang G
Cell Mol Biol Lett; 2024 Mar; 29(1):43. PubMed ID: 38539084
[TBL] [Abstract][Full Text] [Related]
60. Identification of circ_0058357 as a regulator in non-small cell lung cancer cells resistant to cisplatin by miR-361-3p/ABCC1 axis.
Chu D; Li P; Li Y; Shi J; Huang S; Jiao P
Thorac Cancer; 2021 Nov; 12(21):2894-2906. PubMed ID: 34523261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
